Balancing Internal Focus Against External Capabilities.

CURRENT good manufacturing practices; LIFE sciences; PHARMACOLOGY; MANUFACTURING industries; PHARMACISTS' attitudes; CONTRACTS; DECISION making; PHARMACEUTICAL industry; MEDICAL research; CONTRACTING out; COVID-19 pandemic

The article explores in pharmaceutical science several divergent paths typically exhibit clear validity. Decisions often boil down to embracing instead of eschewing risk, to accelerate as the only priority, or to trust a partner rather than emphasize self-reliance. Each molecule, each company or research group possessing that molecule, has an assortment of strengths and weakness to guard against or to leverage.